| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |